An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: A staging system in need of repair

Cancer

Volumn 119, Issue 1, 2013, Pages 81-89

  Dahlstrom, Kristina R ^a   Calzada, Gabriel ^a,b   Hanby, Jennifer D ^a,c   Garden, Adam S ^a   Glisson, Bonnie S ^a   Li, Guojun ^a   Roberts, Dianna B ^a   Weber, Randal S ^a   Sturgis, Erich M ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b KAISER PERMANENTE   (United States)

^c Acadian Ear Nose Throat and Facial Plastic Surgery Center   (United States)

Author keywords

head and neck cancer; head and neck neoplasms; human papillomavirus; neoplasm staging; oropharyngeal cancer

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; CONTROLLED STUDY; DRINKING BEHAVIOR; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE; RETROSPECTIVE STUDY; SEX; SMOKING HABIT; SURVIVAL PREDICTION; TERTIARY HEALTH CARE; TONGUE TUMOR; TONSIL TUMOR; TREND STUDY; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

AGED; CARCINOMA, SQUAMOUS CELL; DEMOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84872792937     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27727     Document Type: Article

References (33)

1. Shiboski CH, Schmidt BL, Jordan RC,. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer. 2005; 103: 1843-1849.
2. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-619.
3. Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ,. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control. 2000; 11: 489-495.
4. Sturgis EM, Cinciripini PM,. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007; 110: 1429-1435.
5. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP,. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005; 114: 806-816.
6. Sturgis EM, Ang KK,. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Canc Netw. 2011; 9: 665-673.
7. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006; 119: 2620-2623.
8. Hammarstedt L, Dahlstrand H, Lindquist D, et al. The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol. 2007; 127: 988-992.
9. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009; 125: 362-366.
10. Attner P, Du J, Nasman A, et al. The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer. 2010; 126: 2879-2884.
11. Giovino GA,. The tobacco epidemic in the United States. Am J Prev Med. 2007; 33 (6 suppl): S318-S326.
12. Gillison ML, Shah KV,. Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol. 2001; 13: 183-188.
13. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer. 2001; 92: 2875-2884.
14. D'souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356: 1944-1956.
15. Ernster JA, Sciotto CG, O'Brien MM, et al. Rising incidence of oropharyngeal cancer and the role of oncogenic human papillomavirus. Laryngoscope. 2007; 117: 2115-2128.
16. Chen AY, Schrag N, Hao Y, Stewart A, Ward E,. Changes in treatment of advanced oropharyngeal cancer, 1985-2001. Laryngoscope. 2007; 117: 16-21.
17. Surveillance, Epidemiology, and End Results. Fast stats: an interactive tool for access to SEER cancer statistics. Bethesda, MD: Surveillance Research Program, National Cancer Institute; 2011. Available at: http://seer.cancer.gov/ faststats. Accessed September 25, 2011.
18. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; 92: 709-720.
19. Ritchie JM, Smith EM, Summersgill KF, et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer. 2003; 104: 336-344.
20. Strome SE, Savva A, Brissett AE, et al. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res. 2002; 8: 1093-1100.
21. Ragin CC, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007; 121: 1813-1820.
22. Mehta V, Yu GP, Schantz SP,. Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics. Laryngoscope. 2010; 120: 2203-2212.
23. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100: 261-269.
24. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363: 24-35.
25. Rischin D, Young RJ, Fisher R, et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol. 2010; 28: 4142-4148.
26. Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J,. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009; 27: 1992-1998.
27. Posner MR, Lorch JH, Goloubeva O, et al. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial. Ann Oncol. 2011; 22: 1071-1077.
28. Cuzick J,. A Wilcoxon-type test for trend. Stat Med. 1985; 4: 87-90.
29. Zhang HP, Singer B,. Recursive Partitioning and Applications. New York: Springer; 2010.
30. Davies L, Welch HG,. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg. 2006; 135: 451-457.
31. Pytynia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM,. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J Clin Oncol. 2004; 22: 3981-3988.
32. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008; 26: 3138-3146.
33. Kreimer AR, Clifford GM, Boyle P, Franceschi S,. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14: 467-475.